viii, 162 pages : illustrations (some color) ; 26 cm
ISBNs
9781573318136, 1573318132
OCLC
ocn672383172
"This volume presents manuscripts stemming from the conference entitled "Innate Inflammation as the Common Pathway of Risk Factors Leading to Transient Ischemic Attacks and Stroke: Pathophysiology and Potential Interventions" held May 9-10, 2010 at the New York Academy of Sciences."--Contents p.
Cover title.
Includes bibliographical references.
Also available on the Internet.
Introduction to innate inflammation: the common denominator of risk factors leading to stroke and TIA -- How inflammation modulates central nervous system vessel activation and provides targets for intervention: a personal perspective -- Innate inflammation as the common pathway of risk factors leading to TIAs and stroke -- Platelet-leukocyte interactions link inflammatory and thromboembolic events in ischemic stroke -- The challenge of mixed cerebrovascular disease -- Pharmacological modulation of vascular inflammation in atherothrombosis -- NF-KB and innate immunity in ischemic stroke -- The role of the blood transcriptome in innate inflammation and stroke -- The neurovascular unit, matrix proteases, and innate inflammation -- Biphasic actions of HMGB1 signaling in inflammation and recovery after stroke -- Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy -- Effect of dipyridamole during acute stroke: exploring antithrombosis and neuroprotective benefits -- Protecting against ischemia-reperfusion injury: antiplatelet drugs, statins, and their potential interactions -- Reperfusion of chronic tissue ischemia: nitrite and dipyridamole regulation of innate immune responses -- Effect of intravenous administration of dipyridamole in a rat model of chronic cerebral ischemia -- Impact of innate inflammation in population studies -- Innate inflammation in myocardial perfusion and its implication for heart failure -- Linking infection and inflammation in acute ischemic stroke -- Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? -- Role of drug absorption in the pharmacokinetics of therapeutic interventions for stroke -- Acute anti-inflammatory approaches to ischemic stroke -- Combating innate inflammation: a new paradigm for acute treatment of stroke? -- Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials